Literature DB >> 15780044

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.

Yi-Hsiang Huang1, Jaw-Ching Wu, Chien-Hung Chen, Ting-Tsung Chang, Pui-Ching Lee, Gar-Yang Chau, Wing-Yiu Lui, Full-Young Chang, Shou-Dong Lee.   

Abstract

PURPOSE: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are two important factors in the development of hepatocellular carcinoma (HCC). The carcinogenic mechanism of HBV and HCV is considered to be different. It is interesting to compare the recurrence after hepatic resection in patients with small HCC who were infected with HBV or HCV.
METHODS: From 1991 to 1995, 145 patients who were positive for hepatitis B surface antigen (HBsAg) or antibody to HCV (anti-HCV) and diagnosed as small HCC (< or =3 cm) in three medical centers in Taiwan were evaluated in this study. All patients underwent hepatic resection. Among them, 83 (57.2%) were infected by HBV, 51 (35.2%) were infected by HCV, and 11 (7.6%) had dual HBV and HCV infection.
RESULTS: Anti-HCV+ HCCs were associated with older age, lower serum albumin, higher alanine transaminase (ALT) level and multi-nodular tumors during diagnosis. During the follow-up, 92 (63.4%) patients developed tumor recurrence. Anti-HCV + HCC had a higher cumulated recurrence rate than HBsAg+ HCC (72.4% vs 53.6 % at 5 year, P = 0.032). In multivariate analysis, the presence of vascular invasion and lower serum albumin levels (<3.9 g/dl) were the determinants for tumor recurrence.
CONCLUSIONS: HCV infection, as compared with HBV infection, had a higher cumulated recurrence after hepatic resection in patients with small HCC. Low serum albumin level was significantly associated with recurrence among these patients. Copyright Blackwell Munksgaard 2005

Entities:  

Mesh:

Year:  2005        PMID: 15780044     DOI: 10.1111/j.1478-3231.2005.01081.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  24 in total

1.  Clinical outcome of hepatectomy for hepatocellular carcinomas≤2 cm.

Authors:  Tokihiko Sawada; Keiichi Kubota; Junji Kita; Masato Kato; Takayuki Shiraki; KyungHwa Park; Mitsugi Shimoda
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

2.  Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.

Authors:  Albert C Y Chan; Sheung Tat Fan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

3.  Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma.

Authors:  Nader N Massarweh; James O Park; Farhood Farjah; Raymond S W Yeung; Rebecca Gaston Symons; Thomas L Vaughan; Laura-Mae Baldwin; David R Flum
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

Review 4.  Staging systems for hepatocellular carcinoma: Current status and future perspectives.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Hisao Tajiri
Journal:  World J Hepatol       Date:  2015-03-27

5.  A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.

Authors:  Wei-Yu Kao; Chien-Wei Su; Gar-Yang Chau; Wing-Yiu Lui; Chew-Wun Wu; Jaw-Ching Wu
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

6.  Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.

Authors:  Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

Review 7.  Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.

Authors:  Po-Ming Wang; Na-Na Chung; Wei-Chung Hsu; Feng-Ling Chang; Chin-Jyh Jang; Marta Scorsetti
Journal:  Rep Pract Oncol Radiother       Date:  2015-04-30

8.  Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Kazunari Sasaki; Junichi Shindoh; Yujiro Nishioka; Georgios A Margonis; Toshitaka Sugawara; Nikolaos Andreatos; Masaji Hashimoto; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-01-03       Impact factor: 3.452

9.  Predictors of recurrence in hepatitis C virus related hepatocellular carcinoma after hepatic resection: a retrospective cohort study.

Authors:  Mohamed Abdel Wahab; Ahmed Shehta; Hosam Hamed; Ayman El Nakeeb; Tarek Salah
Journal:  Eurasian J Med       Date:  2014-02

10.  Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.

Authors:  Jawed Iqbal; Steven McRae; Krishna Banaudha; Thi Mai; Gulam Waris
Journal:  J Biol Chem       Date:  2013-11-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.